Non Malignant Disorders
Palvella and Ligand partner for Phase III rare lymphatic tumour trial
Palvella Therapeutics has partnered with Ligand Pharmaceuticals for the Phase III clinical trial investigating topical Qtorin rapamycin for the treatment…
Pipeline Moves: Pfizer terminates glomerulosclerosis trial, advancement prospects drop
This week on Pipeline Moves, we start off by looking at the terminations of a Phase II focal segmental glomerulosclerosis…